Multiple treatment comparisons in epilepsy monotherapy trials

Smith, CT, Marson, AG ORCID: 0000-0002-6861-8806, Chadwick, DW and Williamson, PR ORCID: 0000-0001-9802-6636 (2007) Multiple treatment comparisons in epilepsy monotherapy trials Trials, 8 (1). 34-. ISSN 1745-6215, 1745-6215

PDF 1745-6215-8-34.pdf - Unspecified Available under License Creative Commons Attribution. Download (324kB)

Abstract

Background: The choice of antiepileptic drug for an individual should be based upon the highest quality evidence regarding potential benefits and harms of the available treatments. Systematic reviews and meta-analysis of randomised controlled trials should be a major source of evidence supporting this decision making process. We summarise all available individual patient data evidence from randomised controlled trials that compared at least two out of eight antiepileptic drugs given as monotherapy. Methods: Multiple treatment comparisons from epilepsy monotherapy trials were synthesized in a single stratified Cox regression model adjusted for treatment by epilepsy type interactions and making use of direct and indirect evidence. Primary outcomes were time to treatment failure and time to 12 month remission from seizures. A secondary outcome was time to first seizure. Results: Individual patient data for 6418 patients from 20 randomised trials comparing eight antiepileptic drugs were synthesized. For partial onset seizures (4628 (72%) patients), lamotrigine, carbamazepine and oxcarbazepine provide the best combination of seizure control and treatment failure. Lamotrigine is clinically superior to all other drugs for treatment failure but estimates suggest a disadvantage compared to carbamazepine for time to 12 month remission [Hazard Ratio (95% Confidence Interval) = 0.87(0.73 to 1.04)] and time to first seizure [1.29(1.13 to 1.48)]. Phenobarbitone may delay time to first seizure [0.77(0.61 to 0.96)] but at the expense of increased treatment failure [1.60(1.22 to 2.10)]. For generalized onset tonic clonic seizures (1790 (28%) patients) estimates suggest valproate or phenytoin may provide the best combination of seizure control and treatment failure but some uncertainty remains about the relative effectiveness of other drugs. Conclusion: For patients with partial onset seizures, results favour carbamazepine, oxcarbazepine and lamotrigine. For generalized onset tonic clonic seizures, results favour valproate and phenytoin. © 2007 Smith et al; licensee BioMed Central Ltd.

Item Type:	Article
Additional Information:	10 pages (page numbers not for citation purposes). Published: 5 November 2007.
Uncontrolled Keywords:	MULTICENTER COMPARATIVE TRIAL, RANDOMIZED CONTROLLED-TRIAL, TONIC CLONIC SEIZURES, CONTROLLED CLINICAL-TRIAL, NEWLY-DIAGNOSED EPILEPSY, SODIUM VALPROATE, DOUBLE-BLIND, NETWORK METAANALYSIS, CHILDHOOD EPILEPSY, ELDERLY-PATIENTS
Subjects:	?? R1 ?? ?? RC0321 ??
Divisions:	Faculty of Health & Life Sciences > Inst. Systems, Molec & Integrative Biology > Inst. Systems, Molec & Integrative Biology Faculty of Health & Life Sciences
Depositing User:	Symplectic Admin
Date Deposited:	06 Jun 2008 11:20
Last Modified:	24 Jan 2026 00:17
DOI:	10.1186/1745-6215-8-34
Publisher's Statement :	© 2007 Smith et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Related Websites:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/675
Disclaimer:	The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.